Effects of lifestyle counseling and combination lipid-modifying therapy on lipoprotein-associated phospholipase A2 mass concentration

This publication has 31 references indexed in Scilit:

• Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study
  Clinical Therapeutics, 2007
• Dynamics of dense electronegative low density lipoproteins and their preferential association with lipoprotein phospholipase A2
  Journal of Lipid Research, 2007
• Effects of Extended-Release Niacin on Lipoprotein Particle Size, Distribution, and Inflammatory Markers in Patients With Coronary Artery Disease
  The American Journal of Cardiology, 2006
• Heart Disease and Stroke Statistics—2006 Update
  Circulation, 2006
• Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000
  European Heart Journal, 2005
• The effect of statin therapy on lipoprotein associated phospholipase A2 levels
  Atherosclerosis, 2005
• Effects of Atorvastatin Versus Other Statins on Fasting and Postprandial C-Reactive Protein and Lipoprotein-Associated Phospholipase A2 in Patients With Coronary Heart Disease Versus Control Subjects
  The American Journal of Cardiology, 2005
• Experimental Studies Defining ω‐3 Fatty Acid Antiinflammatory Mechanisms and Abrogation of Tumor‐Related Syndromes
  Nutrition in Clinical Practice, 2005
• Effects of Prolonged Intensive Lipid-Lowering Therapy on the Characteristics of Carotid Atherosclerotic Plaques In Vivo by MRI
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
• Lipoprotein-Associated Phospholipase A ₂ , Platelet-Activating Factor Acetylhydrolase, Is Expressed by Macrophages in Human and Rabbit Atherosclerotic Lesions
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999